systematic_review
    2020
    High Quality

    Antioxidants for female subfertility

    Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ

    Published in Cochrane Database of Systematic Reviews

    Methodology

    Cochrane systematic review and meta-analysis of randomised trials of oral antioxidant supplementation in subfertile women, with live birth and clinical pregnancy as primary outcomes.

    Key Findings

    Evidence that any single oral antioxidant improves live birth in subfertile women is of low or very low quality; several included trials were later retracted or flagged, though editors judged findings unchanged after their removal.

    Conclusions

    There is no high-quality evidence that antioxidant supplementation increases live birth rates in subfertile women.

    Limitations

    Included trials small and at high risk of bias; nine studies subject to retraction or expression of concern.

    Supplements Studied

    Vitamin E
    Vitamin

    Antioxidants for female subfertility.

    Melatonin
    Compound

    low-quality evidence shows no difference in a lower dose of melatonin being associated with an increased live-birth rate compared with higher-dose melatonin (OR 0.94, 95% CI 0.41 to 2.15; P = 0.89, I2 = 0%; 2 RCTs, 140 women)

    Myo-Inositol
    Compound

    Low-quality evidence suggests that antioxidants may improve clinical pregnancy rate compared with placebo or no treatment/standard treatment (OR 1.65, 95% CI 1.43 to 1.89; P < 0.001, I2 = 63%; 35 RCTs, 5165 women)

    Vitamin D
    Vitamin

    Investigators compared oral antioxidants, including: combinations of antioxidants, N-acetylcysteine, melatonin, L-arginine, myo-inositol, carnitine, selenium, vitamin E, vitamin B complex, vitamin C, vitamin D+calcium, CoQ10, and omega-3-polyunsaturated fatty acids versus placebo

    Outcomes Measured

    Due to the very low-quality of the evidence we are uncertain whether antioxidants improve live birth rate compared with placebo or no treatment/standard treatment (odds ratio (OR) 1.81, 95% confidence interval (CI) 1.36 to 2.43; P < 0.001, I2 = 29%; 13 RCTs, 1227 women)

    Related Health Concerns

    Study Details

    Year:2020
    Quality Score:9/10

    Disclosures

    Funding

    Cochrane/academic

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.